|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 15/11 | |
| C07K 14/705 | |||
| A61K 38/17 | |||
| A61K 39/395 |
| (11) | Number of the document | 1642973 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05018985.1 |
| Date of filing the European patent application | 2000-01-07 | |
| (97) | Date of publication of the European application | 2006-04-05 |
| (45) | Date of publication and mention of the grant of the patent | 2009-07-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 226533 | 1999-01-07 | US |
| (72) |
Gross, Jane A., US
Xu, Wenfeng, US
Madden, Karen, US
Yee, David P., US
|
| (73) |
ZymoGenetics, Inc.,
1201 Eastlake Avenue East, Seattle, WA 98102,
US
|
| (54) | Therapeutic uses of BR43X2 soluble receptors |
| Therapeutic uses of BR43X2 soluble receptors |